Transcorneal electrical stimulation (TES) is a therapy developed for use in patients with a variety of eye diseases. The procedure involves placing electrodes in the form of contact lenses upon the patient's corneas, with a reference electrode on the skin near each eye. A weak current is delivered through the electrodes, with the intent of stimulating the visual system and enhancing its activity.
As of 2022, the technique was still in the early stages of research in human patients. A review of literature published in 2020 estimated this therapy as "probably effective" in the treatment of
retinitis pigmentosa
Retinitis pigmentosa (RP) is a member of a group of genetic disorders called inherited retinal dystrophy (IRD) that cause loss of vision. Symptoms include trouble seeing at night and decreasing peripheral vision (side and upper or lower visua ...
, based on the evidence available at the time.
References
Ophthalmology
{{Ophthalmology-stub